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Because insulin acutely enhances the function of dopamine transporters, the tyrosine kinase receptors activated by this hormone may
modulate transporter-dependent neurochemical and behavioral effects of psychoactive drugs. In this respect, we examined the effects of
insulin on exocytotic monoamine release and the efficacy of the monoamine transporter blocker cocaine in rat nucleus accumbens.
Whereas insulin reduced electrically evoked exocytotic [ 3H]dopamine release in nucleus accumbens slices, the hormone potentiated the
release-enhancing effect of cocaine thereon. The phosphatidylinositol 3-kinase inhibitor LY294002 abolished these effects, indicating the
involvement of insulin receptors. Similar insulin effectswere observedon the release of [ 3H]norepinephrine innucleus accumbens slices,
but not on that of [ 3H]serotonin, and were also apparent in medial prefrontal cortex slices. As might then be expected, insulin also
potentiated the dopamine and norepinephrine release-enhancing effects of the selective monoamine uptake inhibitors GBR12909 and
desmethylimipramine, respectively. In subsequent behavioral experiments, we investigated the role of insulin inmotor impulsivity that
depends onmonoamine neurotransmission in the nucleus accumbens. Intracranial administration of insulin in the nucleus accumbens
alone reduced premature responses in the five-choice serial reaction time task and enhanced the stimulatory effect of peripheral cocaine
administration on impulsivity, resembling the observed neurochemical effects of the hormone. In contrast, cocaine-induced locomotor
activity remained unchanged by intra-accumbal insulin application. These data reveal that insulin presynaptically regulates cocaine-
sensitive monoamine transporter function in the nucleus accumbens and, as a consequence, impulsivity. Therefore, insulin signaling
proteins may represent targets for the treatment of inhibitory control deficits such as addictive behaviors.
Introduction
The pancreatic hormone insulin rapidly crosses the blood–brain
barrier and activates insulin receptors that are widely expressed
throughout the brain (Woods et al., 2000). These tyrosine kinase
receptors are enriched in neurons and found in cell bodies and
nerve terminal membranes of neurons in hypothalamic and
higher limbic regions (Marks et al., 1988; Schulingkamp et al.,
2000). Accordingly, insulin not only acts at hypothalamic sites as
regulator of energy homeostasis in the periphery, but may also
modulate cognitive performance and motivation (Kern et al.,
2001; Zhao and Alkon, 2001; Figlewicz and Benoit, 2009). Nota-
bly, neuronal activity in the brain evoked by a peripheral insulin
injection was attenuated in nondiabetic humans with peripheral
insulin resistance, being most marked in the nucleus accumbens
(NAc) and medial prefrontal cortex (mPFC). Hence, central in-
sulin resistancemay exist in peripheral insulin resistance in brain
regions that play an important role in cognition and motivation
(Anthony et al., 2006).
Regarding the role of insulin in the behavioral effects of natu-
ral reinforcers and addictive drugs, the hormone appeared to
acutely enhance the clearance of synaptically released dopamine
(DA) by increasing the cell surface expression and/or function of
the DA transporter (DAT) in DA nerve terminals (Patterson et
al., 1998; Owens et al., 2005; Williams et al., 2007; Lute et al.,
2008; Figlewicz andBenoit, 2009). SinceDAT is amajor target for
amphetamine and cocaine (Giros et al., 1996; Rothman and
Baumann, 2003), insulin receptors might therefore play a role in
the cognitive and/or motivational effects of psychostimulants.
Considering the regulatory role of insulin in central monoamine
release, studies have primarily focused on the effects of amphet-
amine on nonexocytotic DA release in the striatum of insulin-
depleted rats and on DA release from cultured neurons. Such
studies revealed that activation of insulin receptors, via stimula-
tion of the insulin receptor substrate-2 (IRS-2)/phosphatidylino-
sitol 3-kinase (PI3K) pathway, sustains DAT function in DA
nerve terminals (Williams et al., 2007: Lute et al., 2008), which is
required for psychostimulants to enhanceDAneurotransmission
(Khoshbouei et al., 2004).
To examine such a role of insulin in monoamine transporter
function innondiabetic rats, we investigated the effects ofNAc insu-
linoncocaine-sensitiveexocytoticmonoaminereleaseandoninhib-
itory response control (motor impulsivity). To that end, the effects
of insulin on the electrically evoked release of (radiolabeled) DA,
norepinephrine (NE) and serotonin [5-hydroxytryptamine (5-
HT)], and the transporter-dependent release-enhancing effects
of cocainewere studied in superfusedNAc slices. Considering the
region-specificity of these effects, such experiments were also
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performed with slices of the caudate putamen (CP), the mPFC,
and the orbitofrontal cortex (OFC). Moreover, we examined the
effects of intracranial insulin infusions in the NAc on motor im-
pulsivity induced by intraperitoneal administration of cocaine by
means of the five-choice serial reaction time task (5-CSRTT),
designed to tax monoamine-dependent inhibitory response pro-
cesses (Cole andRobbins, 1989; Pattij andVanderschuren, 2008).
Finally, to investigate whether insulin may affect behaviors that
engagemonoamine neurotransmission in general, the locomotor
effects of NAc insulin were also studied.
Materials andMethods
Subjects. Male Wistar rats (250 g; Harlan) were housed in pairs in
Macrolon cages under a reversed 12 h light/dark cycle (lights on at 7:00
P.M.) at controlled room temperature (21 2°C) and relative humidity
of 60 15%. For the 5-CSRTT experiments, animals weremaintained at
90% of their free-feeding weight, starting 1 week before the beginning
of the experiments by restricting the amount of standard rodent food
pellets (Harlan Teklad Global Diet). Water was available ad libitum
throughout the entire experiment. All experiments were conducted with
the approval of the animal ethical committee of the VU University.
Materials. [ 3H]norepinephrine (35 Ci/mmol), [ 3H]5-hydroxytrypt-
amine (15.9 Ci/mmol), and [3H]dopamine (41 Ci/mmol) were pur-
chased from the Radiochemical Center (GE Healthcare). Insulin,
desmethylimipramine, and fluvoxamine were obtained from Sigma,
GBR12909 from Research Biochemicals, LY294002 from Calbiochem,
and leptin from Bachem. Cocaine hydrochloride was obtained from
OPG.
Superfusion of brain slices. Rats were decapitated, their brains rapidly
removed, and the NAc, mPFC, CP, or OFC dissected from 1-mm-thick
coronal slices using the atlas of Paxinos andWatson (1986). Slices (0.3
0.3  1 mm) were prepared using a McIlwain tissue chopper. For each
experiment, brain slices from six animals were pooled, then incubated
with radiolabeled DA, NE, or 5-HT as described previously (Schof-
felmeer et al., 1988). In short, slices were washed twice with 5 ml of
Krebs–Ringer’s bicarbonate medium containing the following (in mM):
121 NaCl, 1.87 KCl, 1.17 KHPO4, 1.17 MgSO4, 25 NaHCO3, 1.2 CaCl2,
and 10 D-()glucose, pH 7.4. Subsequently, the slices were incubated for
15 min in this medium, containing either 5 Ci [ 3H]DA, [ 3H]NE, or
[ 3H]5-HT under an atmosphere of 95%O2-5%CO2 at 37°C. Incubation
of the slices with [ 3H]DA was performed in the presence of 3 M of the
selective NE transporter (NET) inhibitor desmethylimipramine to pre-
vent accumulation of [ 3H]DA in noradrenergic nerve terminals, and
incubation with [ 3H]NE and [3H]5-HT was done in the presence of 10
M of the selective DAT inhibitor GBR12909 to prevent their accumula-
tion in dopaminergic nerve terminals. After labeling, the slices were
washed and transferred to each of 24 chambers of a superfusion appara-
tus (3 mg tissue per chamber, 0.2 ml volume) and superfused (0.25
ml/min) with medium gassed with 95%O2-5% CO2 at 37°C. The super-
fusate was collected as 10 min samples. After 40 min of superfusion (t
40 min), calcium-dependent and tetrodotoxin-sensitive (exocytotic)
neurotransmitter release was induced during superfusion by exposing
the slices to electrical biphasic 2 ms block pulses ([ 3H]NE release: 1 Hz,
10mA current; [ 3H]DA and [3H]5-HT release: 1 Hz, 30mA current) for
10 min (electrical-field stimulation). Drugs (insulin, cocaine, LY294002,
desmethylimipramine, fluvoxamine, GBR12909, and leptin) were added
to the medium 20 min before electrical stimulation of the slices and
remained present until the end of the experiment. In each experiment, six
observations and experiments were repeated three or four times.
Calculation of release data. To determine exocytotic neurotransmitter
release in the slices, the radioactivity remaining at the end of the super-
fusion experiment was extracted from the tissue with 0.1 N HCl. The
radioactivity in superfusion fractions and tissue extracts was determined
by liquid scintillation counting. The efflux of radioactivity during each
collection period was expressed as a percentage of the amount of radio-
activity in the slices at the beginning of the respective collection period.
The electrically evoked neurotransmitter release was calculated by sub-
tracting the spontaneous efflux of radioactivity from the total overflow of
radioactivity during stimulation and the following 10 min. Because neu-
rotransmitter release returned to basal levels during the next 10 min
period, a linear decline from the 10min interval before to the 20–30min
after the onset of stimulationwas assumed for calculation of spontaneous
efflux of radioactivity. Independent of the brain region investigated, this
spontaneous efflux of radioactivity amounted to 3% of total tissue
radioactivity in slices labeled with [ 3H]DA or [3H]NE and to 9% of
total tissue radioactivity in slices labeled with [ 3H]5-HT. At the concen-
trations used, none of the drugs examined altered spontaneous tritium
efflux from the slices. The electrically evoked release was expressed as
percentage of the content of radioactivity of the slices at the start of the
stimulation period.
The effects of drugs on evoked neurotransmitter release in excess of
spontaneous efflux were analyzed using one-way ANOVA’s, followed by
Student’s Newman–Keuls tests where appropriate. The level of probabil-
ity for statistically significant effects was set at 0.05 (NS, not significant).
Behavioral training in the five-choice serial reaction time task. Detailed
description of the behavioral apparatus and training in the 5-CSRTT has
been provided previously (van Gaalen et al., 2006). In short, rats were
trained to detect and respond to a 1 s visual stimulus in one of five
apertures, during presentation of the stimulus, or during a 2 s limited
hold period to obtain a food reward (45mg, Formula P; Research Diets).
Each session terminated after 100 trials or 30 min, whichever occurred
first. Initially, the duration of this stimulus was 32 s and was gradually
decreased to 1 s over sessions until animals reached stable baseline per-
formance (accuracy, 80% correct choice and 20% errors of omis-
sion). Incorrect, premature responses (responses during the 5 s intertrial
interval) and errors of omission did not lead to the delivery of a food
reward and resulted in a 5 s time-out period during which the house light
was extinguished. Responses during the time-out period resulted in a
new time-out period. Perseverative responses, i.e., repeated responding
during the presentation of the stimulus were measured but did not have
any programmed consequences. The following behavioral measures
were recorded: (1) percentage premature responses [(number premature
responses)/(correct incorrect responses omissions) 100], (2) ac-
curate choice [(number correct responses)/(correct  incorrect re-
sponses)  100], (3) latency of correct responses, (4) percentage
omissions [(number omissions)/(correct incorrect responses omis-
sions)  100], (5) feeder latency, i.e., time to collect food reward after
correct choice, and (6) perseverative responses after correct choice.
Behavioral data were analyzed using two-factor repeated-measures
ANOVAswith insulin (vehicle or insulin) and cocaine (saline or cocaine)
treatment as within-subject factors. Significant insulin cocaine inter-
action effects indicate differential effects of insulin on cocaine’s effects on
performance. In case of significant interaction effects, further analyses
were conducted using paired-samples t tests.
Surgery and infusion procedure. Three days before surgery, the food
restriction schedule in 5-CSRTT experiments was terminated and rats
had ad libitum access to food. For surgery, rats were anesthetized using a
combination of xylazine (Rompun, 7 mg/kg, i.p.; Bayer) and ketamine
(100 mg/kg, i.m.; Alfasan), then placed in a stereotaxic instrument
(David Kopf Instruments) for placement of an indwelling bilateral guide
cannula (model C235G; Plastics One). The coordinates used for place-
ment of the cannulae in the NAc were as follows: 1.7 mm rostral to
bregma, 6.4 mm ventral to the skull, and 1.0 mm lateral to midline
calculated from Paxinos and Watson (1998). Following surgery, the an-
imals were housed individually and had ad libitum access to food 1 week
before retraining in the 5-CSRTT.
Intracranial infusions in the 5-CSRTT experiments were performed
when stable baseline performance was reestablished, and during this pe-
riod animals were habituated twice to intraperitoneal saline injections.
Initially, during two sham infusion sessions, animals were habituated to
insertion of a bilateral injector extending 1mmbeyond the guide cannula
(model C235I; PlasticsOne). During the infusion experiments, insulin (2
M) or vehicle was infused over a period of 1 min at a rate of 0.5 l/min
using 10 l Hamilton syringes driven by a syringe infusion pump (Har-
vard Apparatus). Following infusion, the injector remained in place for
an additional minute to allow diffusion of insulin; the rats were tested 10
min later. For the combination study of insulin pretreatment and intra-
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peritoneal cocaine, immediately following the infusion procedure rats
were injected with vehicle or cocaine (5 mg/kg) and tested 10 min later.
Measurement of locomotor activity. For the locomotor activity experi-
ments, animals were equipped with bilateral cannulae aimed at the NAc,
as described above. Horizontal motor activity was measured in Perspex
cages (40 40 35 cm) using a video tracking system (Ethovision Pro v.
2.3.21;Noldus InformationTechnology), which determined the position
of the animal five times per second. All experiments were conducted
between 9:30 A.M. and 4:30 P.M. in the dark phase of the day/night cycle.
Locomotor activity was assessed. On d 1, animals were allowed to habit-
uate to the test cage for 2 h, during which activity wasmonitored. On d 2,
the rats were again habituated to the test cage for 1 h, after which insulin
(2M) or vehiclewas intracranially infused, followed by an injectionwith
cocaine or saline. Locomotor activity was monitored for an additional
hour. A dose of 10 mg/kg intraperitoneal cocaine was administered to
consistently increase locomotor activity, as preliminary experiments re-
vealed that 5 mg/kg cocaine was not sufficient. Data were analyzed using
a repeated-measures ANOVA with treatment as between-subjects and
time as within-subjects factor.
Assessment of cannula placement. Following completion of the behav-
ioral procedures, animals were deeply anesthetized using sodium pentobar-
bital (60 mg/ml, i.p.; Ceva Sante Animale). Subsequently, animals were
perfused transcardially with 100ml of 0.9%NaCl, followed by 500ml of 4%
paraformaldehyde in 0.1 M PBS, pH 7.2. Brains were removed rapidly and
postfixed for1h in the same fixative, thenstored in20%sucrose in0.1MPBS,
both at 4°C. Coronal sections of 40 m were cut on a cryostat and subse-
quently stained with thionin for determination of the infusion sites.
Results
Acute effect of insulin on DA release and its enhancement by
cocaine in NAc slices
Overall, the electrically evoked release of [3H]DA in superfused
NAc slices in excess of spontaneous tritium efflux amounted to
3.30  0.04% of total tissue radioactivity. Insulin slightly, but
significantly, inhibited evoked [3H]DA release in a concen-
tration-dependent manner (Fig. 1A). Since amaximal inhibitory
effect on evoked [3H]DA was obtained at 10 nM (13% inhibi-
tion, F(1,58)  5.27, p  0.05), this concentration of insulin was
used in all subsequent experiments. Cocaine dose-dependently
enhanced electrically evoked [3H]DA release, reaching its maxi-
mal effect at 1 M. Figure 1B shows that insulin profoundly po-
tentiated this effect of cocaine. Accordingly, whereas 1 M
cocaine increased electrically evoked [3H]DA release from 3.16%
to 3.79% of total tissue tritium in the absence insulin (20% in-
crease, F(1,46) 5.00, p 0.05), cocaine increased evoked release
from 2.74% to 3.93% of total tissue tritium in the presence of
insulin (43% increase, F(1,46)  12.16, p  0.01). Thus, insulin
more than doubled the relative effect of 1 M cocaine on exocy-
totic DA release in NAc slices, indicating that insulin enhanced
DAT function in DA nerve terminals.
In the presence of 10 M of the selective PI3K inhibitor
LY294002, the inhibitory effect of insulin on electrically evoked
[3H]DA release was no longer observed. In these experiments,
evoked [3H]DA release in the absence and presence of 10 nM
insulin amounted to 3.25% and 2.91% of total tissue tritium,
respectively (F(1,46) 4.67, p 0.05) and to 3.21% and 3.31% of
total tissue tritium, respectively (F(1,46)  0.21, NS) when
LY294002 was also present in the superfusion medium. Figure 2
shows that, in the presence of 10 nM insulin, the stimulatory effect of
cocaine on electrically evoked [3H]DA release was approximately
twofold higher than that in the absence of the hormone (F(1,46) 
10.24, p 0.01). In the presence of LY294002, however, insulin did
notpotentiate theeffectof cocaineonevoked[3H]DArelease (F(1,46)
 0.10, NS), indicating the involvement of insulin receptors.
Since insulin tended to enhance electrically evoked release of
[3H]DA in the presence of cocaine (F(1,94)  2.69, p  0.07),
rather than inhibiting release as observed in the absence of co-
caine, it is conceivable that the hormone also has a slight release-
enhancing effect, independent of enhancement of DAT function,
that is unmasked upon DAT blockade.
Specificity of the regulatory role of insulin on
monoamine transporter function
The electrically evoked release of [3H]DA in CP, mPFC, and OFC
slices in excess of spontaneous tritium efflux amounted to 2.53 
Figure 1. A, B, The effect of insulin on the electrically evoked [ 3H] DA release (A) and on
the release-enhancing effect of cocaine (B) in NAc slices. Slices, incubated with [ 3H] DA (in
the presence of 3M desmethylimipramine), were superfused and stimulated electrically
at t 40 min for 10 min. Insulin and cocaine were added to the superfusion medium 20
min before depolarization and were present until the end of the experiment. Data are
expressed as percentage of electrically evoked [ 3H]DA release observed in the absence of
insulin (A) and as percentage of electrically evoked [ 3H]DA release in the absence (closed
circles) or presence (open circles) of 10 nM insulin (B). Data represent means SEM of
24 –30 observations. *p 0.05, significantly different from control release; **p 0.05,
significantly different from effect of cocaine in the absence of insulin. resp. control, Re-
spective control; conc., concentration.
Figure2. ThePI3K inhibitor LY294002blocks the insulin-induced increase of theDA release-
enhancing effect of cocaine inNAc slices. Slices, incubatedwith [ 3H]DA (in the presence of 3M
desmethylimipramine), were superfused and stimulated electrically at t 40 min for 10 min.
Insulin (10 nM), 1M cocaine (COC) and 10M LY294002 (LY) were added to the superfusion
medium 20 min before depolarization and were present until the end of the experiment. Data
are expressed as percentage of respective control (resp. control) [ 3H]DA release in excess of
spontaneous tritium efflux, i.e., evoked release in the absence and presence of insulin. Data
representmeans SEMof 24observations. *p0.01, significantly different from theeffect of
cocaine in the absence of insulin.
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0.06%, 12.53  0.24%, and 7.16  0.12% of total tissue tritium,
respectively. Insulin slightly inhibited evoked [3H]DA release from
mPFC slices (9% inhibition, F(1,46) 4.57, p 0.05), but did not
alter evoked neurotransmitter release from CP and OFC slices (CP:
F(1,46) 0.26, NS; OFC: F(1,46) 0.31, NS).
As indicated in Figure 3, cocaine (1M) ap-
peared to increase the evoked release of
[3H]DA in slices of each of these brain re-
gions (F(1,46)  4.31–6.56, p  0.05). In
mPFCslices, the [3H]DArelease-enhancing
effect of cocainewaspotentiated in thepres-
ence insulin (F(1,46)  5.21, p  0.05), as
observed in NAc slices.
The electrically evoked [3H]NE release
in NAc, CP, mPFC, and OFC slices
amounted to 8.23 0.21%, 9.54 0.26%,
5.52  0.14%, and 6.18  0.20% of total
tissue tritium, respectively. Insulin only
caused a reduction of the evoked release of
[3H]NE (10% inhibition) from NAc
slices (F(1,58)  4.12, p  0.05) and mPFC
slices (F(1,58)  4.32, p  0.05). Under the
present experimental conditions, cocaine (1
M) did not enhance evoked [3H]NE re-
lease in NAc slices in the absence of insulin
(F(1,46) 0.54, NS). As observed regarding
the evoked release of [3H]DA, insulin po-
tentiated the release-enhancing effect of co-
caine on [3H]NE release inNAc andmPFC
slices (F(1,46)  4.76 and 5.21, respectively,
p 0.05), leaving the effect of cocaine inCP
and OFC slices unchanged (F(1,46)  0.46
and 0.68, respectively, NS) (Fig. 3).
The electrically evoked release of
[3H]5-HT in slices of theNAc, CP,mPFC,
and OFC amounted to 5.04  0.15%,
6.08  0.19%, 6.52  0.23%, and 8.27  0.28% of total tissue
tritium, respectively. Insulin slightly reduced the evoked release
of [3H]5-HT (10% inhibition, F(1,46)  4.17, p  0.05) and
approximately doubled the release-enhancing effect of cocaine
on evoked [3H]5-HT release in CP slices (F(1,46)  5.38, p 
0.05), but did not alter evoked [3H]5-HT release (F(1,46) 0.17;
NS), nor the effects of cocaine thereon in NAc, mPFC, or OFC
slices (F(1,46) 0.48, 0.61, and 0.59, respectively; NS) (Fig. 3).
Together, the occurrence of an inhibitory effect of insulin on
exocytotic monoamine release was consistently associated with
an enhancement of the relative stimulatory effect of cocaine on
neurotransmitter release in the brain regions investigated, indi-
cating the involvement of an insulin receptor-mediated increase
in monoamine transporter function.
In addition to the brain region and neurotransmitter specific-
ity of the effects of insulin, we investigated whether the adiposity
hormone leptin causes similar presynaptic effects as insulin atDA
nerve terminals. Figure 4 shows that a maximally effective con-
centration (data not shown) of leptin (10 nM) indeed caused an
inhibitory effect on the electrically evoked release of [3H]DA in
NAc slices (F(1,46)  5.84, p  0.05). However, the DA-release
enhancing effect of cocaine appeared to remain unchanged in the
presence of leptin (F(1,46) 0.86, NS).
Effect of insulin on the efficacy of selective inhibitors of
monoamine transporters in NAc slices
As observed with cocaine (see above), the highly selective DAT
inhibitor GBR12909 (1 M) enhanced the electrically evoked re-
lease of [3H]DA in superfused NAc slices (F(1,46)  5.94, p 
0.05). As indicated in Figure 5, this effect of GBR12909 (resulting
Figure 3. Region and neurotransmitter specificity of the regulatory role of insulin receptors. Slices of the NAc, CP,mPFC, or OFC
were incubatedwith [ 3H]DA (in thepresenceof 3Mdesmethylimipramine) or [ 3H]NEor [ 3H]5-HT (both in thepresenceof 10M
GBR12909). Radiolabeled slices were superfused and stimulated electrically at t 40min for 10min. Insulin (10 nM) and cocaine
(1M)were added to the superfusionmedium20minbefore depolarization andwerepresent until the endof the experiment. The
release-enhancing effects of cocaine are expressed as percentage of respective electrically evoked release in the absence or
presence of insulin. Data represent means SEM of 24–30 observations. *p 0.05, significantly different from control release;
**p 0.05, significantly different from the effect of cocaine in the absence of insulin. resp. control, Respective control.
Figure4. Theeffectof leptinontheelectricallyevoked[ 3H]DAreleaseandcocaineefficacy inNAc
slices. Slices, incubated with [ 3H]DA (in the presence of 3M desmethylimipramine), were super-
fused and stimulated electrically at t 40min for 10min. Leptin (10 nM) and cocaine (COC; 1M)
were added to the superfusionmedium20minbeforedepolarizationandwerepresent until the end
of the experiment. The data are expressed as percentage of control [ 3H]DA release in excess of spon-
taneoustritiumeffluxobservedintheabsenceof insulinandcocaine.DatarepresentmeansSEMof
24 observations. *p 0.05, significantly different from control release.
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from blockade of [3H]DA reuptake) was more than doubled by
exposure of the slices to 10 nM insulin (F(1,46) 9.53, p 0.01).
Moreover, the selective NET inhibitor desmethylimipramine (1
M) enhanced the electrically evoked [3H]NE release (F(1,46) 
8.64, p 0.01), provided that insulin was added to the superfu-
sion medium. Figure 5 also shows that the selective serotonin
transporter (SERT) inhibitor fluvoxamine (1 M) similarly en-
hanced the electrically evoked release of [3H]5-HT from NAc
slices in the absence or presence of insulin (F(1,46) 0.11, NS).
Effect of intracranial infusion of insulin in the NAc on
cocaine-sensitive inhibitory control
In these experiments, 16 rats were trained in the 5-CSRTT.
Two animals were excluded from all analyses; one rat died
during the surgical procedure and one rat did not meet per-
formance criteria during task acquisition and was therefore
excluded. During test sessions, rats completed all 100 trials.
Since preliminary experiments revealed that local administra-
tion of insulin in the NAc reduced premature responding in
the 5-CSRTT and that a 2 M insulin infusion was optimally
effective in this respect, we further examined the effect of this
concentration of insulin on cocaine-sensitive inhibitory control.
As we have previously shown (vanGaalen et al., 2006), cocaine (5
mg/kg, i.p.) increased premature responding (F(1,13) 36.76, p
0.001). Most importantly, in addition to its inhibitory effect on
impulsivity, NAc insulin (2 M) appeared to profoundly poten-
tiate the relative stimulatory effect of cocaine (Fig. 6) (insulin
cocaine interaction: F(1,13)  6.97, p 
0.05). Thus, in the absence of insulin, co-
caine increased premature responding
from 23.5% to 38.1% (62% increase; t(13)
 2.26, p 0.05), whereas in the presence
of insulin, this relative increase in prema-
ture responding by cocaine occurred to a
much larger extent, i.e., from 12.3% to
47.1% (283% increase; t(13)  7.61, p 
0.001). Interestingly, these behavioral
observations closely resemble the neuro-
chemical effects of insulin on neurotrans-
mitter release described above. With
regard to other behavioral parameters in
the 5-CSRTT, some modest significant ef-
fects were found following NAc insulin in-
fusion and peripheral cocaine injections
(Table 1). Thus, NAc insulin increased ac-
curate choice compared with vehicle infu-
sion (t(13)  2.99, p  0.01; main effect
insulin: F(1,13) 0.79, NS; cocaine: F(1,13)
0.46, NS; insulin  cocaine: F(1,13)  6.56,
p 0.05) and cocaine by itself increased the
number of omissions compared with all
other drug combinations (vehicle/saline,
t(13)3.43,p0.005; insulin/saline, t(13)2.68,p0.005; insulin/
cocaine, t(13) 2.42, p 0.05;main effect insulin:F(1,13) 2.31,NS;
cocaine: F(1,13) 7.22, p 0.05; insulin cocaine: F(1,13) 10.91,
p 0.01). Finally, the combination of insulin and cocaine speeded
response latencies compared with vehicle/saline treatment (t(13) 
2.55, p  0.05; main effect insulin: F(1,13)  5.86, p  0.05;
cocaine: F(1,13)  0.43, NS; insulin  cocaine: F(1,13)  3.80,
NS). Feeder latencies were not altered by administration of
insulin, cocaine, or their combination (insulin: F(1,13) 2.59,
NS; cocaine: F(1,13)  1.00, NS; insulin  cocaine: F(1,13) 
1.78, NS).
Effect of intracranial infusion of insulin in the NAc on
cocaine-induced locomotor activity
Initially, thirty-two rats were equipped with cannulae aimed at
the NAc and the effects of insulin and cocaine or their combi-
nation on locomotor activity were tested in a between-subjects
design with eight animals per treatment. Two animals died
during surgery, and three animals were excluded due to can-
nula misplacement (resulting group sizes: vehicle  saline,
n  8; vehicle  cocaine, n  7; insulin  saline, n  6, and
insulin  cocaine, n  6).
Figure 5. The effect of insulin on the efficacy of monoamine transporter inhibitors in the
NAc. Slices of the NAc were incubated with [ 3H]DA (in the presence of 3M desmethylimipra-
mine), or [ 3H]NE or [ 3H]5-HT (both in the presence of 10M GBR12909). Radiolabeled slices
were superfused and stimulated electrically at t 40 min for 10 min. Insulin (10 nM; INS),
GBR12909 (1M; GBR), desmethylimipramine (1M; DMI) or fluvoxamine (1M; FLU) were
added to the superfusionmedium 20min before depolarization andwere present until the end
of the experiment. The release-enhancing effects of the uptake inhibitors were expressed as
percentageof respective control (resp. control) release in excess of spontaneous tritiumefflux in
the absenceor presenceof insulin. Data representmeans SEMof 24observations. *p0.05,
significantly different from control release in the absence of insulin; **p 0.01, significantly
different from the effect of cocaine in the absence of insulin.
Figure 6. Effect of NAc insulin on motor impulsivity in the 5-CSRTT. Left, Schematic drawing of coronal sections depicting
cannula placement into theNAc [adopted fromPaxinos andWatson (1998)]. Right, Effects of intracranial application of insulin into
the NAc on motor impulsivity and on the stimulatory effect of cocaine (5 mg/kg i.p.; COC). Note that the effects of cocaine on
premature responding amounted to60%and280%of respective control values in the absence (openbars) andpresence (closed
bars) of insulin. *p 0.05 and ** p 0.005, significantly different from vehicle/saline; ##significantly different from insulin/
saline ( p 0.001).
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Unlike intraperitoneal administration of 5 mg/kg cocaine
(data not shown) (Herges and Taylor, 1999), a dose of 10 mg/kg
caused a consistent hyperlocomotor response (Fig. 7) (treatment:
F(3,23) 10.80, p 0.001; time treatment: F(33,253) 7.15, p
0.001). Further analyses revealed that both groups treated with
cocaine differed from the saline-treated groups. In contrast to the
behavioral effects in the cognitive task, insulin (2 M) infusion
into the NAc did not alter the locomotor effects of cocaine (treat-
ment: F(1,11) 0.36, NS; time treatment: F(11,121) 0.37, NS).
Likewise, insulin by itself did also not alter the distance traveled
compared with vehicle and saline-treated controls (treatment:
F(1,12) 0.17, NS; time treatment: F(11,132) 0.42, NS).
Discussion
Our present neurochemical and behavioral data show, for the
first time, that (1) insulin enhances cocaine-sensitive mono-
amine transporter function in rat NAc, thereby displaying brain-
region specificity, and (2) NAc insulin reduces impulsive
behavior and enhances cocaine-induced impulsivity, in agree-
ment with the crucial role of monoamine neurotransmission in
theNAc in inhibitory response control. Therefore, the pancreatic
hormone insulin may play a role in inhibitory control deficits
such as that observed in drug abuse, obesity, and attention deficit
hyperactivity disorder (ADHD).
Considering the involvement of insulin in cognitive andmotiva-
tional processes that depend on DA neurotransmission, insulin re-
ceptors and their downstream substrates (IRS-2 and PI3K) in rat
brain are densely expressed in DA neurons within the ventral teg-
mental area (VTA) and activation of these receptors enhances PI3K
activity andDATmRNAexpression(Figlewiczet al., 1994;Pardini et
al., 2006; Figlewicz and Benoit, 2009). Moreover, insulin receptor
activation appeared to increase the surface expression and function
of DAT in rat striatum, enhancing DA reuptake in a P13K-
dependent manner (Patterson et al., 1998; Carvelli et al., 2002;
Garcia et al., 2005; Lute et al., 2008). Similarly, insulin
receptor-mediated PI3K activation may acutely promote NET
activity in nerve terminals, albeit without altering its cell sur-
face expression (Apparsundaram et al., 2001). Experimentally
induced diabetes appeared to reduce
amphetamine-stimulated psychomotor
activity, presumably through insulin-
regulated DAT activity in the striatum
(Marshall, 1978; Murzi et al., 1996;
Owens et al., 2005). Accordingly,
streptozocin-induced hypoinsulinemia
attenuated the DA-releasing action of
amphetamine by inhibiting PI3K signal-
ing downstream of insulin receptors and
reducing the surface expression and
function of DAT in the striatum
(Carvelli et al., 2002; Galici et al., 2003;
Williams et al., 2007; Lute et al., 2008).
These studies suggest that behavioral ef-
fects of amphetamine mediated by stri-
atal DA release are insulin-dependent.
However, since central neuroadapta-
tions may occur upon long-lasting insu-
lin depletion, the use of a diabetic model
may not be ideal to assess the acute ef-
fects of insulin on normal brain func-
tion. Therefore, we examined the role of
insulin in cocaine-sensitive monoamine
transporter function and monoamine
release neurochemically and behavior-
ally under nonpathological conditions, i.e., in nondiabe-
tic rats.
We found that insulin alone inhibited electrically evoked
[3H]DA release and potentiated the (relative) stimulatory effect
of cocaine and that of the selective DAT inhibitor GBR12909 on
exocytotic DA release in NAc slices, indicating enhanced DAT
function.Moreover, the selective PI3K-inhibitor LY294002 abol-
ished these insulin effects, indicating the involvement of insulin
receptor signaling. Such acute effects of insulin were also ob-
served in mPFC slices, but not in DS and OFC slices. These data
suggest that insulin primarily regulates DAT activity in the pre-
frontal cortical–ventral striatal pathway that mediates the neuro-
cognitive effects of addictive drugs (Everitt and Robbins, 2005;
Pattij and Vanderschuren, 2008). Regarding the specificity of this
insulin effect, the adiposity hormone leptin similarly reduced
evoked DA release in NAc slices. Apparently, leptin not only
inhibits the activity of DA neurons within the VTA (Hommel et
al., 2006), but also reduces DA neurotransmission presynapti-
cally in the NAc. In this respect, it is of interest to note that NAc
DA release appeared to be reduced (rather than enhanced) in
leptin-deficient (ob/ob) mice (Fulton et al., 2006), indicating that
chronic reduction of leptin levels in mutant mice may cause neu-
roadaptations in DA neurons. The inhibitory effect of leptin on
NAc DA release, in contrast to that of insulin, was not associated
with potentiation of release-enhancing effect of cocaine, indicat-
ing that leptin does not exert its presynaptic inhibitory action by
enhancing DAT function, but perhaps through hyperpolariza-
tion as in the VTA (Hommel et al., 2006).
Figure 7. NAc insulin does not affect locomotor activity. Left, Schematic drawing of coronal sections depicting cannula place-
ment into the NAc [adopted from Paxinos andWatson (1998)]. Right, Lack of effects of intracranial application of insulin into the
NAc on locomotor activity and on the stimulatory effect of cocaine (10 mg/kg i.p.). VEH, Vehicle; SAL, saline; COC, cocaine.
Table 1. Effects of intra-accumbal insulin (2M) and systemic cocaine (5mg/kg,
i.p.) on auxiliary behavioral measures in the 5-CSRTT
Accurate
choice (%)
Response
latency (ms) Omissions
Feeder
latency (ms)
Vehicle–saline 80.9 2.4 318 9 7.6 1.1 1264 105
Vehicle– cocaine 83.5 1.7 314 12 16.1 2.5* 1851 427
Insulin–saline 85.4 2.2* 325 13 9.1 1.3 1265 99
Insulin– cocaine 80.8 2.2 298 8* 9.8 1.3 1623 326
Data are means SEM obtained in 14 rats. *p 0.05, compared to vehicle–saline treatment.
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Although cocaine blocks DAT, NET, and SERT function
(Rothman and Baumann, 2003), the psychoactive effects of co-
caine primarily involve enhanced DA neurotransmission. How-
ever, depending on the behavioral effect of cocaine, enhancedNE
and 5-HT release (upon blockade of NET and SERT) may also
play a role (Drouin et al., 2002; Homberg et al., 2008; Hall et al.,
2009). Therefore, we also examined the effect of insulin on the
evoked [3H]NE and [3H]5-HT release and its enhancement by
cocaine in brain slices. Cocaine (and the selective NET inhibitor
desmethylimipramine) only enhanced evoked [3H]NE release
from NAc slices when insulin was added to the superfusion me-
dium. Apparently, only in the presence of insulin does [3H]NE
reuptake play a prominent role in determining the overall efflux
of the neurotransmitter from NAc slices measured under our
superfusion conditions.Moreover, insulin strongly enhanced the
stimulatory effect of cocaine on [3H]NE release in mPFC slices,
but did not affect it in CP or OFC slices. In contrast, insulin only
potentiated the effect of cocaine on [3H]5-HT release in CP
slices. Since an inhibitory effect of insulin on electrically evoked
monoamine release in brain slices was associated with potentia-
tion of the release-enhancing effect of monoamine transporter
blockers, our study reveals that insulin presynaptically enhances
the function of monoamine transporters in frontal cortical and
striatal rat brain regions.
Given these distinct neurochemical effects of insulin, the hor-
mone may play a modulatory role in various cognitive and mo-
tivational processes. In this respect, we also studied the role of
NAc insulin in cocaine-sensitive impulsive action, since mono-
amine neurotransmission in the NAc is crucial for inhibitory
response control and cocaine-induced motor impulsivity in rats
(Cole and Robbins, 1987, 1989; van Gaalen et al., 2006; Pezze et
al., 2007; Pattij et al., 2007; Pattij and Vanderschuren, 2008). We
observed that insulin infused into the NAc reduced premature
responses in the 5-CSRTT, resembling its inhibitory effect on
monoamine release in this brain region. Moreover, as observed
for the monoamine-release enhancing effects of cocaine, the in-
crease in impulsivity induced by a peripheral injection of cocaine
was potentiated by application of insulin into the NAc. These
observations suggest that insulin receptors may modulate
cocaine-sensitive inhibitory response control by enhancing
monoamine transporter function in the NAc. Importantly, the
profound behavioral effects of NAc insulin on 5-CSRTT perfor-
mance were restricted to impulsive behavior since only modest
effects were found on other behavioral parameters. Of particular
interest in this regard, NAc insulin slightly improved visuospatial
attention, consistent with the role of NAc DA neurotransmission
in visuospatial attention (Pattij et al., 2007; Pezze et al., 2007) and
an inverse relationship between impulsivity and visuospatial at-
tention (Dalley et al., 2008).
Considering the role of monoamine receptors in the effects of
insulin on inhibitory response control, activation of D1 as well as
D2/3 DA receptors in the NAc is known to enhance motor im-
pulsivity in rats (Van Gaalen et al., 2006, Dalley et al., 2007; Pattij
et al., 2007). Although this also holds true for psychostimulant-
induced locomotor activity (Ikemoto, 2002), we did not find an
effect of NAc insulin on locomotor activity and its enhancement
by cocaine, indicating that NAc insulin does not affect behaviors
that engage the DA system in general.
The role of insulin in monoamine transporter function and
impulsivity that we discovered may have important patho-
physiological implications. For instance, regarding motiva-
tion for food, intraventricular insulin (and leptin) application
in rats appeared to reverse place preference conditioned with a
high-fat diet (Figlewicz et al., 2004) and to reduce sucrose
self-administration (Figlewicz et al., 2006). Moreover, consider-
ing the prevalence of obesity and type 2 diabetes, a high-fat diet
and genetic obesity is known to cause insulin resistance in rat
brain attenuating the central inhibitory effect of insulin on food
intake (Figlewicz and Benoit, 2009). Since peripheral insulin re-
sistance in nondiabetic humans appears to be associated with
attenuated insulin-evoked responses in the brain (Anthony et al.,
2006), it is possible that individuals with insulin resistance are at
risk of obesity because of altered functioning of the insulin-
sensitive mesocorticolimbic system and its progressive dysregu-
lation upon consumption of highly palatable foods. With regard
to the role of NAc insulin in impulsive behavior, it is of interest
that impulsivity is often associated with drug abuse (Coffey et al.,
2003) and obesity (Nederkoorn et al., 2006) and that there is a
considerable incidence of drug addiction (Wilens, 2004) and
obesity (Cortese et al., 2008) in patients suffering fromADHD. In
this respect, recent studies showed that motor impulsivity in rats
may be a risk factor for the initiation of drug abuse, the switch to
compulsive drug-seeking and cue-induced relapse behavior
(Dalley et al., 2007; Belin et al., 2008; Diergaarde et al., 2008,
Economidou et al., 2009). Moreover, we showed that poor im-
pulse control in rats not only predicts behavioral hyperrespon-
siveness to cocaine and nicotine, but also escalation of sucrose
seeking and hypersensitivity to sucrose-associated stimuli (Dier-
gaarde et al., 2009). It is therefore conceivable that individual
differences in brain insulin levels or insulin sensitivity play a role
in addiction (including obesity) proneness. Future studies, for
example, on the behavioral effects of altered insulin receptor gene
expression in the NAc, should shedmore light on the pathophys-
iological impact of our findings. This is of importance, since tar-
geting insulin receptor signaling in the brainmay provide a novel
pharmacotherapy for inhibitory control disorders such as drug
addiction, obesity, and ADHD.
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